InvestorsHub Logo
icon url

TheExpertHimself

05/12/15 10:25 PM

#75555 RE: Deep Space #75554

the higher the stock price, the better the liquidity situation for Musclepharm.

The current liquidity situation is tight but ANB bank has not sold any of Musclepharm's treasury stock in it's escrow account.

Furthermore, most of Musclepharm's Q1 loss was an accounting loss according to GAAP. EBITDA was only slightly in the red which ain't too bad considering that Musclepharm had to dig itself out of a hole from Q4....

It does appear that Musclepharm has some issues meeting demand, but as long as it can grow revenue with $10 million per quarter, the marketing expense is not wasted.